UCLA awarded $1.72M NIH grant to train brain cancer scientists

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting urinary side effects after receiving radiation therapy.

April 11, 2025

Vol.51 No.14

Podcast

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).

April 04, 2025

Vol.51 No.13

By Claire Marie Porter, Paul Goldberg and Jacquelyn Cobb

Clinical Roundup

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

A study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer to develop resistance to therapy. Researchers at Baylor College of Medicine showed that lipid accumulation in tumor cells and nearby immune cells promotes immune suppression, but disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.

April 04, 2025

Vol.51 No.13

Podcast

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

“For the last 50 years every major medical breakthrough can be traced back to investments in the NIH, which houses the National Cancer Institute (NCI),” said Wayne A. I. Frederick, interim chief executive officer of American Cancer Society and the American Cancer Society Cancer Action Network.

April 02, 2025

Vol.51 No.12

In Brief

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Michael Chan was appointed chair of Wake Forest University’s Department of Radiation Oncology, which he has led as interim chair since 2023. In his permanent role, he will advance the clinical, research and education missions of the department, while optimizing care delivery and clinical operations.

March 28, 2025

Vol.51 No.12

UCLA awarded $1.72M NIH grant to train brain cancer scientists

YOU MAY BE INTERESTED IN

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

In The Headlines: Private funding can’t replace federal funding—but it can help

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Renew today!

Subscriber content

Never miss an issue!

Login

UCLA awarded $1.72M NIH grant to train brain cancer scientists

YOU MAY BE INTERESTED IN

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

In The Headlines: Private funding can’t replace federal funding—but it can help

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDAMeanwhile, NASEM sounds “SOS” for health infrastructure

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Never miss an issue!

Login

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure